证券记录 · 已归档季度
LH
Labcorp Holdings Inc. · Healthcare · Medical - Diagnostics & Research
11被追踪持有人
—Δ持有人
5.93M持有股份
$1.21B报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 158 | +5 | 56.58M | $15.83B | +9 | −3 |
| Q1 2026 | 155 | +1 | 55.32M | $14.74B | +4 | −4 |
| Q4 2025 | 153 | -1 | 61.82M | $15.50B | +1 | −1 |
| Q3 2025 | 19 | 0 | 33.10M | $9.50B | — | −1 |
| Q2 2025 | 17 | -1 | 30.31M | $7.95B | +1 | −2 |
| Q1 2025 | 15 | +2 | 7.94M | $1.85B | +2 | — |
| Q4 2024 | 13 | 0 | 9.58M | $2.20B | +2 | −2 |
| Q3 2024 | 12 | +1 | 4.32M | $962.67M | +2 | −1 |
| Q2 2024 | 11 | — | 5.93M | $1.21B | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 2.23M | — | $453.25M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 2.23M | — | $453.25M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 2.23M | — | $453.25M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.23M | — | $453.25M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.23M | — | $453.25M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.23M | — | $453.25M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 2.23M | — | $453.25M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Geode Capital Management ✦ (被动) | 1.95M | — | $396.05M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Geode Capital Management ✦ (被动) | 1.95M | — | $396.05M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Norges Bank ✦ (被动) | 1.03M | — | $209.67M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 282.96K | — | $57.53M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 282.96K | — | $57.53M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 282.96K | — | $57.53M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 282.96K | — | $57.53M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | Bridgewater Associates ✦ | 207.51K | — | $42.23M | 0.2% | n/c | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 117.05K | — | $23.82M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 117.05K | — | $23.82M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 71.08K | — | $14.47M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 71.08K | — | $14.47M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Adage Capital Partners ✦ | 20.90K | — | $4.25M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Millennium Management ✦ | 19.93K | — | $4.06M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Marshall Wace ✦ | 1.50K | — | $305,265 | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Fisher Asset Management ✦ | 1.25K | — | $253,908 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,014 持有人, 76.41M 股份, $19.36B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 17
ANDERSON KERRII B
Director · 3.00K 股 · $954,060
Aug 11
Schechter Adam H
Officer, Director · 4.67K 股 · $1.50M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据